Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma
出版年份 2020 全文链接
标题
Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma
作者
关键词
-
出版物
Cancer Medicine
Volume 9, Issue 5, Pages 1721-1732
出版商
Wiley
发表日期
2020-01-20
DOI
10.1002/cam4.2838
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial
- (2019) C Zhao et al. ANNALS OF ONCOLOGY
- Relationship of Circulating Tumor Cells and Epstein‐Barr Virus DNA to Progression‐Free Survival and Overall Survival in Metastatic Nasopharyngeal Carcinoma Patients
- (2019) Rui You et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical characteristics and prognostic value of pre‐retreatment plasma epstein‐barr virus DNA in locoregional recurrent nasopharyngeal carcinoma
- (2019) Ming‐Zhu Liu et al. Cancer Medicine
- Anti-epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
- (2018) Hao Peng et al. CANCER SCIENCE
- Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
- (2018) K.H. Au et al. ORAL ONCOLOGY
- A Prognostic Score for Nasopharyngeal Carcinoma with Bone Metastasis: Development and Validation from Multicenter
- (2018) Chen Chen et al. Journal of Cancer
- Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
- (2018) Fangzheng Wang et al. Journal of Cancer
- Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma
- (2018) Ji-Jin Yao et al. CANCER BIOLOGY & THERAPY
- Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
- (2018) Yun-Ming Tian et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up
- (2017) Rui You et al. Theranostics
- Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: A meta-analysis
- (2017) Xuelei Ma et al. Cancer Biomarkers
- Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
- (2016) Li Zhang et al. LANCET
- Nasopharyngeal carcinoma
- (2016) Melvin L K Chua et al. LANCET
- Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status
- (2016) Wei Zheng et al. PLoS One
- Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma
- (2013) Lei Ma et al. FEBS Journal
- Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment
- (2013) Yun-Ming Tian et al. Radiation Oncology
- Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities
- (2013) Xueming Sun et al. RADIOTHERAPY AND ONCOLOGY
- Assessment of prognostic factors after primary tumor resection in metastatic colon cancer patients: A Veteran's Affairs Central Cancer Registry (VACCR) analysis, 1995-2008
- (2012) Wilson I. Gonsalves et al. JOURNAL OF SURGICAL ONCOLOGY
- A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
- (2011) B. B. Y. Ma et al. ANNALS OF ONCOLOGY
- Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
- (2011) Jill Wykosky et al. Chinese Journal of Cancer
- Prognostic factors in 1038 women with metastatic breast cancer
- (2008) R. Largillier et al. ANNALS OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started